Yes, mechanical AVR (aortic valve replacement) is performed with a mechanical prosthetic valve.
Mechanical AVR refers specifically to aortic valve replacement surgery using a mechanical (metal/carbon) prosthetic valve, as opposed to a bioprosthetic (tissue) valve. This is the standard terminology used in cardiothoracic surgery and cardiology 1, 2.
Key Distinctions in Valve Types
When surgeons and cardiologists discuss AVR, they distinguish between:
- Mechanical AVR: Replacement with a durable mechanical valve (e.g., St. Jude, On-X valves) made of pyrolytic carbon and metal alloys
- Bioprosthetic AVR: Replacement with tissue valves (bovine/porcine pericardium or homografts)
- TAVI/TAVR: Transcatheter approach using bioprosthetic valves
Clinical Decision Framework by Age
The 2020 ACC/AHA guidelines provide clear age-based recommendations 1, 2:
For patients <50 years old:
- Mechanical AVR is preferred if no contraindication to anticoagulation exists
- Offers superior durability and avoids early reintervention
- Recent data confirms survival benefit up to age 70 3
For patients 50-65 years old:
- Individualized choice between mechanical and bioprosthetic valves
- Consider patient willingness for lifelong anticoagulation
- Mechanical valves show lower long-term mortality in this age group 3, 4
For patients >65 years old:
- Bioprosthetic valves are preferred
- Higher bleeding risk from anticoagulation outweighs reintervention risk
- TAVI becomes an option for ages 65-80 2
Trade-offs of Mechanical Valves
Advantages:
- Exceptional durability (typically lifelong)
- Lower risk of reintervention 4
- Survival benefit in patients ≤70 years 3
Disadvantages:
- Mandatory lifelong vitamin K antagonist (VKA) anticoagulation
- Higher risk of anticoagulation-related bleeding 4
- Dietary restrictions and INR monitoring requirements
- Restrictions on certain athletic activities
Common Pitfall
The most significant clinical pitfall is implanting bioprosthetic valves in younger patients (<65 years) who can tolerate anticoagulation. Despite increasing bioprosthetic use across all age groups 5, 6, evidence consistently shows mechanical valves provide superior long-term survival in patients ≤70 years 3, 4. The convenience of avoiding anticoagulation must be weighed against the near-certainty of structural valve deterioration requiring reintervention within 10-15 years in younger patients 1.
Absolute contraindications to mechanical AVR include:
- Inability to manage anticoagulation appropriately
- Patient refusal of lifelong anticoagulation
- Planned pregnancy (relative contraindication due to warfarin teratogenicity) 1